These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 27167350)

  • 1. Production and Characterization of Novel Camel Single Domain Antibody Targeting Mouse Vascular Endothelial Growth Factor.
    Kazemi-Lomedasht F; Behdani M; Habibi-Anbouhi M; Shahbazzadeh D
    Monoclon Antib Immunodiagn Immunother; 2016 Jun; 35(3):167-71. PubMed ID: 27167350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of nanobodies against epithelial cell adhesion molecule as novel theranostic agents for cancer therapy.
    Roshan R; Naderi S; Behdani M; Cohan RA; Ghaderi H; Shokrgozar MA; Golkar M; Kazemi-Lomedasht F
    Mol Immunol; 2021 Jan; 129():70-77. PubMed ID: 33183767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection and Characterization of Specific Nanobody Against Human Immunoglobulin G.
    Kazemi-Lomedasht F; Behdani M; Rahimpour A; Habibi-Anbouhi M; Poshang-Bagheri K; Shahbazzadeh D
    Monoclon Antib Immunodiagn Immunother; 2015 Jun; 34(3):201-5. PubMed ID: 26090598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligoclonal selection of nanobodies targeting vascular endothelial growth factor.
    Ahadi M; Ghasemian H; Behdani M; Kazemi-Lomedasht F
    J Immunotoxicol; 2019 Dec; 16(1):34-42. PubMed ID: 30409071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of angiogenesis in human endothelial cell using VEGF specific nanobody.
    Kazemi-Lomedasht F; Behdani M; Bagheri KP; Habibi-Anbouhi M; Abolhassani M; Arezumand R; Shahbazzadeh D; Mirzahoseini H
    Mol Immunol; 2015 May; 65(1):58-67. PubMed ID: 25645505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreaction of a recombinant nanobody from camelid single domain antibody fragment with Acinetobacter baumannii.
    Payandeh Z; Rasooli I; Mousavi Gargari SL; Rajabi Bazl M; Ebrahimizadeh W
    Trans R Soc Trop Med Hyg; 2014 Feb; 108(2):92-8. PubMed ID: 24463583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation and identification of anti-follicle-stimulating hormone receptor nanobodies].
    Xia X; M M; Zhai T; Li J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):829-33. PubMed ID: 23948408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of Novel VHH Nanobody Inhibiting Angiogenesis by Targeting Binding Site of VEGF.
    Ebrahimizadeh W; Mousavi Gargari SL; Javidan Z; Rajabibazl M
    Appl Biochem Biotechnol; 2015 Aug; 176(7):1985-95. PubMed ID: 26054617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microcystin-LR nanobody screening from an alpaca phage display nanobody library and its expression and application.
    Xu C; Yang Y; Liu L; Li J; Liu X; Zhang X; Liu Y; Zhang C; Liu X
    Ecotoxicol Environ Saf; 2018 Apr; 151():220-227. PubMed ID: 29353171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel nanobody against urease activity of Helicobacter pylori.
    Ardekani LS; Gargari SL; Rasooli I; Bazl MR; Mohammadi M; Ebrahimizadeh W; Bakherad H; Zare H
    Int J Infect Dis; 2013 Sep; 17(9):e723-8. PubMed ID: 23561799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nanobody directed to a functional epitope on VEGF, as a novel strategy for cancer treatment.
    Farajpour Z; Rahbarizadeh F; Kazemi B; Ahmadvand D
    Biochem Biophys Res Commun; 2014 Mar; 446(1):132-6. PubMed ID: 24569074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation and characterization of nanobodies against rhGH expressed as sfGFP fusion protein.
    Abbady AQ; Al-Shemali R; Mir Assaad J; Murad H
    Gen Comp Endocrinol; 2014 Aug; 204():33-42. PubMed ID: 24859761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fenobody and RANbody-based sandwich enzyme-linked immunosorbent assay to detect Newcastle disease virus.
    Ji P; Zhu J; Li X; Fan W; Liu Q; Wang K; Zhao J; Sun Y; Liu B; Zhou EM; Zhao Q
    J Nanobiotechnology; 2020 Mar; 18(1):44. PubMed ID: 32169061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and applications of Nanobodies against human procalcitonin selected from a novel naïve Nanobody phage display library.
    Yan J; Wang P; Zhu M; Li G; Romão E; Xiong S; Wan Y
    J Nanobiotechnology; 2015 May; 13():33. PubMed ID: 25944262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of nanobodies against prostate-specific membrane antigen (PSMA) recognizing LnCaP cells.
    Zare H; Rajabibazl M; Rasooli I; Ebrahimizadeh W; Bakherad H; Ardakani LS; Gargari SL
    Int J Biol Markers; 2014 Jun; 29(2):e169-79. PubMed ID: 24425321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIM28 and β-actin identified via nanobody-based reverse proteomics approach as possible human glioblastoma biomarkers.
    Jovčevska I; Zupanec N; Kočevar N; Cesselli D; Podergajs N; Stokin CL; Myers MP; Muyldermans S; Ghassabeh GH; Motaln H; Ruaro ME; Bourkoula E; Turnšek TL; Komel R
    PLoS One; 2014; 9(11):e113688. PubMed ID: 25419715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of a novel camel single-domain antibody specific for the type III mutant EGFR.
    Omidfar K; Rasaee MJ; Modjtahedi H; Forouzandeh M; Taghikhani M; Golmakani N
    Tumour Biol; 2004; 25(5-6):296-305. PubMed ID: 15627895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid and Sensitive Detection of Staphylococcal Enterotoxin B by Recombinant Nanobody Using Phage Display Technology.
    Zanganeh S; Rouhani Nejad H; Mehrabadi JF; Hosseini R; Shahi B; Tavassoli Z; Aramvash A
    Appl Biochem Biotechnol; 2019 Feb; 187(2):493-505. PubMed ID: 29984392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of protective agent against Hottentotta saulcyi venom using camelid single-domain antibody.
    Darvish M; Behdani M; Shokrgozar MA; Pooshang-Bagheri K; Shahbazzadeh D
    Mol Immunol; 2015 Dec; 68(2 Pt B):412-20. PubMed ID: 26468036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A camel anti-lysozyme CDR3 only domain antibody selected from phage display VHH library acts as potent lysozyme inhibitor.
    Qiu L; Feng Y; Ma X; Li J
    Acta Biochim Biophys Sin (Shanghai); 2017 Jun; 49(6):513-519. PubMed ID: 28475681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.